17. SHAREHOLDERS’ EQUITY AND SHARE-BASED COMPENSATION

On January 30, 2023, the Company closed a public offering (the "Offering") of 18,350,000 Common Shares at a price of US$1.35 per share together with accompanying warrants to purchase up to 18,350,000 Common Shares, which have an exercise price of US$1.65 per share (the "Warrants"). The gross proceeds from the Offering were approximately US$25 million before deducting placement agent fees and other offering expenses payable by the Company. The proceeds from the Offering are being used for general working capital. The accompanying Warrants have an exercise price of US$1.65 and became exercisable beginning six months from issuance and will expire five years from the date of initial exercisability.

Share-based compensation

The Company’s Share-Based Compensation Plan (the “Plan”) dated January 1, 2010, was most recently approved by Shareholders on June 10, 2021. The Plan provides that the number of Common Shares reserved for issuance upon the exercise or redemption of awards granted under the Plan is a rolling maximum of ten percent (10%) of the outstanding Common Shares at any point in time. Approximately 3,262 shares remain available for issuance as of December 31, 2025.

Stock options have been granted with an exercise price equal to the fair market value of the common stock on the date of grants and have a ten-year contractual term. The stock options vest ratably over a 3- year period. Compensation expense is recognized

over the vesting period, using the graded vesting method, by increasing additional paid-in capital based on the number of awards expected to vest. The number of awards expected to vest is reviewed at least annually, with any impact recognized immediately.

The fair market value of stock options is estimated using the Black-Scholes-Merton valuation model and the Company uses the following methods to determine its underlying assumptions: expected volatilities are based on the historical volatilities of the weekly closing price of the Company’s common stock; the expected term of options granted is based historical exercises and forfeitures; the risk-free interest rate is based on Canadian Treasury bonds issued with similar life terms to the expected life of the grant; and the expected dividend yield is based on the current annual dividend amount divided by the stock price on the date of grant. Forfeitures are recorded when incurred.

The following key assumptions were used in the valuation model to value stock option grants for each respective period:

 

 

2025

 

2024

 

2023

Expected volatility

 

75.3% - 78.1%

 

77.2% - 85.8%

 

85.7% - 87.8%

Dividend

 

$nil

 

$nil

 

$nil

Risk-free interest rate

 

3.91% - 4.02%

 

3.08% - 3.71%

 

2.76% - 4.15%

Expected life

 

3.5years

 

4.4 years

 

6.5 years

Fair value

 

$0.33 - $0.62

 

$0.56 - $0.62

 

$0.44 - $0.82

Stock option transactions under the Company’s plan for the years ended December 31, 2025, 2024 and 2023 are summarized as follows:

 

 

Number of
Options

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term (years)

 

 

Aggregate
Intrinsic
Value

 

Exercisable at December 31, 2022

 

 

2,549,401

 

 

$

5.88

 

 

 

5.46

 

 

$

133

 

Granted during 2023

 

 

3,492,991

 

 

$

0.94

 

 

 

9.34

 

 

$

130

 

Exercised during 2023

 

 

(100,000

)

 

$

0.83

 

 

 

 

 

$

71

 

Forfeited during 2023

 

 

(535,833

)

 

$

4.04

 

 

 

 

 

 

 

Outstanding at December 31, 2023

 

 

6,946,576

 

 

$

3.50

 

 

 

7.54

 

 

$

83

 

Exercisable at December 31, 2023

 

 

3,081,262

 

 

$

6.07

 

 

 

5.44

 

 

$

1

 

Granted during 2024

 

 

620,000

 

 

$

0.95

 

 

 

5.96

 

 

$

0

 

Forfeited/expired during 2024

 

 

(598,167

)

 

$

3.32

 

 

 

 

 

 

 

Outstanding at December 31, 2024

 

 

6,968,409

 

 

$

3.50

 

 

 

6.79

 

 

$

90

 

Exercisable at December 31, 2024

 

 

3,081,262

 

 

$

6.07

 

 

 

5.96

 

 

$

31

 

Granted during 2025

 

 

450,000

 

 

$

0.76

 

 

 

5.36

 

 

$

1,300

 

Exercised during 2025

 

 

(791,829

)

 

$

1.03

 

 

 

 

 

 

 

Forfeited/expired during 2025

 

 

(163,834

)

 

$

2.84

 

 

 

 

 

 

 

Outstanding at December 31, 2025

 

 

6,462,746

 

 

$

3.42

 

 

 

5.36

 

 

$

10,869

 

Exercisable at December 31, 2025

 

 

4,615,074

 

 

$

4.41

 

 

 

5.17

 

 

$

5,876

 

The weighted-average grant-date fair value of options granted during the years ended December 31, 2025, 2024 and 2023 was $0.47, $0.58 and $0.71, respectively. The total intrinsic value of options exercised during the years ended December 31, 2025, 2024 and 2023, was $1,535, $0 and $71, respectively.

A summary of the status of the Company’s non-vested stock options, and the changes during the year ended December 31, 2025 is presented below:

 

 

Number of
Options

 

 

Weighted
Average Grant
Date Fair
Value

 

 

Aggregate
Intrinsic Value

 

Non-vested at January 1, 2025

 

 

2,479,553

 

 

$

0.82

 

 

 

 

Granted

 

 

450,000

 

 

$

0.47

 

 

 

 

Vested

 

 

(918,047

)

 

$

0.81

 

 

 

 

Forfeited

 

 

(163,834

)

 

$

1.99

 

 

 

 

Non-vested at December 31, 2025

 

 

1,847,672

 

 

$

0.63

 

 

$

4,993

 

As of December 31, 2025, there was approximately $1,258 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the stock option plan; that cost is expected to be recognized over a period of three years.

The Company has also issued performance-based or time-based restricted share units to Village Farms employees involved with future developments of the Company. Once a performance or time based target is met and the share units are deemed earned and vested, compensation expense is recognized, based on the fair value of the share units on the grant date.

Performance-based and time based restricted share unit activity for the years ended December 31, 2025, 2024 and 2023 is as follows:

 

 

Number of
Performance-based
Restricted Share Units

 

 

Weighted Average
Grant Date Fair Value

 

Exercisable at December 31, 2022

 

 

30,000

 

 

$

8.31

 

Issued

 

 

(10,000

)

 

$

8.31

 

Forfeited

 

 

(20,000

)

 

$

8.31

 

Outstanding at December 31, 2023

 

 

 

 

$

-

 

Exercisable at December 31, 2023

 

 

 

 

$

-

 

Granted

 

 

2,179,884

 

 

$

0.71

 

Vested and Issued

 

 

(1,479,024

)

 

$

1.25

 

Outstanding at December 31, 2024

 

 

700,860

 

 

$

0.17

 

Exercisable at December 31, 2024

 

 

 

 

$

-

 

Granted

 

 

2,812,740

 

 

$

0.72

 

Forfeited

 

 

(267,216

)

 

$

0.60

 

Vested and Issued

 

 

(700,860

)

 

$

0.59

 

Outstanding at December 31, 2025

 

 

2,545,524

 

 

$

0.73

 

Exercisable at December 31, 2025

 

 

 

 

$

-

 

On September 3, 2024, the Company granted 600,000 shares to a director of the Company.

Total share-based compensation for the years ended December 31, 2025, 2024 and 2023 of $1,741, $3,747 and $3,111, respectively, was recorded in selling, general and administrative expenses and the corresponding amount credited to additional paid in capital.

Share buyback program

On September 29, 2025, the Board of Directors authorized a $10 million share repurchase for up to 5,687,000 of the Company’s outstanding common stock. Such purchases may be made on the open market, in private transactions and/or pursuant to purchase plans designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The Company is not obligated to repurchase any specific number of shares, and the timing and actual number of shares repurchased will depend

on a variety of factors, including the Company’s stock price, general economic, business and market conditions, and alternative investment opportunities. The Company may discontinue any repurchases of its common stock at any time without prior notice. During the year ended December 31, 2025, the Company repurchased 812,923 shares for an aggregate amount of $2,971 (excluding the 2% Canadian excise tax on stock repurchases). As of December 31, 2025, $7,041 remains available for repurchases. Shares repurchased by the Company are accounted for when the transaction is settled. As of December 31, 2025, there were no unsettled share repurchases. Direct costs incurred to acquire the shares are included in the total cost of the shares.

Warrants

Warrant activity for the year ended December 31, 2025 was as follows:

 

 

Number of
Shares Underlying the Warrants

 

 

Weighted
Average
Exercise Price

 

 

Weighted
Average
Remaining
Contractual
Term (years)

 

Outstanding at December 31, 2024

 

 

18,350,000

 

 

$

1.65

 

 

 

3.50

 

Exercised

 

 

(2,816,100

)

 

$

1.65

 

 

 

 

Issued

 

 

 

 

$

-

 

 

 

-

 

Expired

 

 

 

 

$

-

 

 

 

-

 

Outstanding at December 31, 2025

 

 

15,533,900

 

 

$

1.65

 

 

 

2.50

 

Historical Timeline

Fiscal YearFiled
2025Mar 12, 2026Showing above
2024Mar 13, 2025
2023Mar 13, 2024

About Stock Compensation Disclosures

Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.

Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.